{"date":"2025-09-19","count":10,"source":"公開資訊觀測站（MOPS）","attribution":"引用請註明：Drugnews 事實帳本（https://drugnews.com.tw/filings/）與公開資訊觀測站原始公告","records":[{"id":"tw-7827-2025-09-19-1946-1vf24ap","company_id":"7827","company":"漢康-KY創","market":"上市","industry":"生技醫療","date":"2025-09-19","time":"19:46:26","subject":"公告本公司114年第一次現金增資全體董事放棄認購股數達得認購股數二分之一以上，並洽特定人認購事宜。","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：漢康-KY創（7827），2025-09-19 19:46，「公告本公司114年第一次現金增資全體董事放棄認購股數達得認購股數二分之一以上，並洽特定人認購事宜。」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7827-2025-09-19-1921-13etwuy","company_id":"7827","company":"漢康-KY創","market":"上市","industry":"生技醫療","date":"2025-09-19","time":"19:21:26","subject":"本公司114年第一次現金增資股款催繳公告","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：漢康-KY創（7827），2025-09-19 19:21，「本公司114年第一次現金增資股款催繳公告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6919-2025-09-19-1759-1az161b","company_id":"6919","company":"康霈*","market":"上市","industry":"生技醫療","date":"2025-09-19","time":"17:59:20","subject":"公告本公司取得固定收益債券","clause":"第20款","fact_date":"2025-09-18","cite_as":"公開資訊觀測站重大訊息：康霈*（6919），2025-09-19 17:59，「公告本公司取得固定收益債券」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6620-2025-09-19-1738-1gxx1cs","company_id":"6620","company":"漢達","market":"上櫃","industry":"生技醫療","date":"2025-09-19","time":"17:38:11","subject":"(補充113/10/22之重訊)代子公司Handa Oncology公告HND-033於美國FDA之查驗登記審查進度，配合本公司之營運現況，經董事會決議調整HND-033之開發策略，不再繼續此新藥申請(NDA)","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：漢達（6620），2025-09-19 17:38，「(補充113/10/22之重訊)代子公司Handa Oncology公告HND-033於美國FDA之查驗登記審查進度，配」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7713-2025-09-19-1642-r4jla2","company_id":"7713","company":"威力德生醫","market":"上櫃","industry":"生技醫療","date":"2025-09-19","time":"16:42:15","subject":"公告本公司國內第一次無擔保轉換公司債代收價款及存儲專戶行庫","clause":"第53款","fact_date":"2025-09-19","cite_as":"公開資訊觀測站重大訊息：威力德生醫（7713），2025-09-19 16:42，「公告本公司國內第一次無擔保轉換公司債代收價款及存儲專戶行庫」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4155-2025-09-19-1536-1ppi0i3","company_id":"4155","company":"訊映","market":"上市","industry":"生技醫療","date":"2025-09-19","time":"15:36:24","subject":"本公司收回已發行之限制員工權利新股辦理註銷減資變更登記完成","clause":"第36款","fact_date":"2025-09-19","cite_as":"公開資訊觀測站重大訊息：訊映（4155），2025-09-19 15:36，「本公司收回已發行之限制員工權利新股辦理註銷減資變更登記完成」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4155-2025-09-19-1535-1ffxuo3","company_id":"4155","company":"訊映","market":"上市","industry":"生技醫療","date":"2025-09-19","time":"15:35:33","subject":"公告本公司辦理庫藏股註銷減資變更登記完成","clause":"第36款","fact_date":"2025-09-19","cite_as":"公開資訊觀測站重大訊息：訊映（4155），2025-09-19 15:35，「公告本公司辦理庫藏股註銷減資變更登記完成」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6876-2025-09-19-1500-54swv6","company_id":"6876","company":"朗齊生醫*","market":"興櫃","industry":"生技醫療","date":"2025-09-19","time":"15:00:22","subject":"公告本公司法人董事改派代表人","clause":"第6款","fact_date":"2025-09-19","cite_as":"公開資訊觀測站重大訊息：朗齊生醫*（6876），2025-09-19 15:00，「公告本公司法人董事改派代表人」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-1762-2025-09-19-1450-m94erf","company_id":"1762","company":"中化生","market":"上市","industry":"生技醫療","date":"2025-09-19","time":"14:50:11","subject":"公告本公司庫藏股註銷減資變更登記完成","clause":"第36款","fact_date":"2025-09-19","cite_as":"公開資訊觀測站重大訊息：中化生（1762），2025-09-19 14:50，「公告本公司庫藏股註銷減資變更登記完成」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4121-2025-09-19-1435-1ks2tm2","company_id":"4121","company":"優盛","market":"上櫃","industry":"生技醫療","date":"2025-09-19","time":"14:35:27","subject":"公告本公司董事會決議註銷庫藏股並訂定減資基準日","clause":"第11款","fact_date":"2025-09-19","cite_as":"公開資訊觀測站重大訊息：優盛（4121），2025-09-19 14:35，「公告本公司董事會決議註銷庫藏股並訂定減資基準日」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"}]}